Predictors of Deteriorating Cerebral Infarct: Role of Inflammatory Mechanisms. Would Its Early Treatment Be Useful?
- 1 February 2001
- journal article
- review article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 11 (Suppl. 1) , 40-48
- https://doi.org/10.1159/000049124
Abstract
The development of neurological deterioration in the hours following the stroke onset occurs in somewhat more than 1 in 3 cerebral infarcts and is associated with an increase in morbidity and mortality. This early deterioration (0–48/72 h) entails the conversion of the ischemic penumbra area in an irreversible lesion, a process that is mediated as much by hemodynamic changes in the local cerebral circulation as by biochemical mechanisms. Late neurological deterioration (3–7 days) is more frequently associated with systemic causes. Knowledge of the various clinical, biochemical and imaging markers associated with neurological deterioration is consequently of fundamental importance. For their repercussion in clinical practice, we classify these predictors of deteriorating cerebral infarct into nonmodifiable, modifiable and possibly modifiable. The reduction in cerebral blood flow in a particular cerebral zone causes very early cerebral damage as a consequence of a significant liberation of neuroexcitatory amino acids, followed by an excessive entry of calcium into the interior of cells; this process causes lipid peroxidation, disintegration of the cellular membranes, nuclear destruction and neuronal death. Moreover, ischemia and posterior reperfusion induce an inflammatory response leading to further cellular destruction. It is therefore conceivable that therapeutic interventions aimed at decreasing proinflammatory cytokines and cell adhesion molecules might result in better outcome in this population.Keywords
This publication has 7 references indexed in Scilit:
- Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II)Published by Elsevier ,1998
- Progression of ischaemic stroke and excitotoxic aminoacidsThe Lancet, 1997
- Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcomeThe Lancet, 1996
- Tissue Plasminogen Activator for Acute Ischemic StrokeNew England Journal of Medicine, 1995
- Effect of blood pressure and diabetes on stroke in progressionThe Lancet, 1994
- Proinflammatory cytokines in serum of patients with acute cerebral ischemia: kinetics of secretion and relation to the extent of brain damage and outcome of diseaseJournal of the Neurological Sciences, 1994
- Leucocyte-endothelial interactions and regulation of leucocyte migrationThe Lancet, 1994